|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.180 USD | -3.59% |
|
-1.44% | -14.29% |
| Market Cap | 187M 167M 154M 140M 262M 17.75B 266M 1.86B 735M 9.3B 702M 687M 29.32B | P/E 2026 * |
-2.06x | P/E 2027 * | -1.49x |
|---|---|---|---|---|---|
| Enterprise Value | 45.98M 41.06M 37.93M 34.37M 64.31M 4.36B 65.37M 456M 181M 2.29B 173M 169M 7.21B | EV / Sales 2026 * |
110x | EV / Sales 2027 * | -360x |
| Free-Float |
47.87% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RNAC | Delayed | |
CBOE
| RNAC | Real-time | |
|
Deutsche Boerse AG
| 1S70 | Delayed | |
|
Boerse Muenchen
| 1S70 | Real-time |
Last Transcript: Cartesian Therapeutics, Inc.
| 1 day | -3.59% | ||
| 1 week | -1.44% | ||
| Current month | -14.29% | ||
| 1 month | -21.47% | ||
| 3 months | -21.97% | ||
| 6 months | -11.33% | ||
| Current year | -14.29% |
| 1 week | 6.01 |  | 6.71 |
| 1 month | 6.01 | | 8.05 |
| Current year | 5.6 | | 11 |
| 1 year | 5.6 | | 11 |
| 3 years | 5.6 | | 42.6 |
| 5 years | 5.6 | | 42.6 |
| 10 years | 5.6 | | 42.6 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/04/26 | Exercice | 758,001 | 2.8594% | |||
| 02/04/26 | Exercice | 22,740 | - | - | ||
| 02/04/26 | Exercice | 22,740 | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.59% | -1.44% | -31.33% | - | 187M | |
| +2.41% | +0.29% | +42.02% | +71.57% | 64.69B | |
| -0.15% | +7.50% | +11.01% | +73.48% | 54.78B | |
| +0.57% | +4.60% | +10.07% | +92.86% | 53.49B | |
| +0.37% | +4.67% | +27.03% | +52.07% | 45.98B | |
| -1.21% | +2.32% | +21.80% | +123.81% | 42.94B | |
| -0.37% | +5.07% | +249.91% | +918.74% | 40.08B | |
| +0.05% | +0.21% | +18.26% | +58.53% | 33.52B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.67B | |
| +1.19% | -4.98% | +29.01% | -0.65% | 23.97B | |
| Average | -0.11% | +2.03% | +41.42% | +157.55% | 38.33B | |
| Weighted average by Cap. | +0.39% | +2.73% | +47.53% | +158.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 419K 374K 346K 313K 586K 39.79M 596K 4.16M 1.65M 20.85M 1.57M 1.54M 65.72M | 286K 255K 236K 214K 400K 27.12M 406K 2.84M 1.12M 14.21M 1.07M 1.05M 44.8M |
| Net income | -88.41M -78.95M -72.94M -66.1M -124M -8.39B -126M -878M -347M -4.4B -332M -325M -13.86B | -144M -129M -119M -108M -201M -13.67B -205M -1.43B -566M -7.16B -540M -529M -22.58B |
| Net Debt | -141M -126M -116M -105M -197M -13.39B -200M -1.4B -554M -7.01B -529M -518M -22.11B | -290M -259M -239M -217M -405M -27.5B -412M -2.88B -1.14B -14.41B -1.09B -1.06B -45.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | US$6.180 | -3.59% | 85,901 |
| 22/10/26 | US$6.410 | -0.16% | 89,200 |
| 21/10/26 | US$6.420 | +0.39% | 105,973 |
| 20/10/26 | US$6.395 | +5.18% | 168,585 |
| 19/10/26 | US$6.080 | -3.03% | 201,517 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RNAC Stock
Select your edition
All financial news and data tailored to specific country editions
